Dermatologic manifestations and complications of COVID-19

Michael Gottlieb, Brit Long, Michael Gottlieb, Brit Long

Abstract

The novel coronavirus disease of 2019 (COVID-19) is associated with significant morbidity and mortality. While much of the focus has been on the cardiac and pulmonary complications, there are several important dermatologic components that clinicians must be aware of.

Objective: This brief report summarizes the dermatologic manifestations and complications associated with COVID-19 with an emphasis on Emergency Medicine clinicians.

Discussion: Dermatologic manifestations of COVID-19 are increasingly recognized within the literature. The primary etiologies include vasculitis versus direct viral involvement. There are several types of skin findings described in association with COVID-19. These include maculopapular rashes, urticaria, vesicles, petechiae, purpura, chilblains, livedo racemosa, and distal limb ischemia. While most of these dermatologic findings are self-resolving, they can help increase one's suspicion for COVID-19.

Conclusion: It is important to be aware of the dermatologic manifestations and complications of COVID-19. Knowledge of the components is important to help identify potential COVID-19 patients and properly treat complications.

Keywords: COVID-19; Coronavirus; Dermatology; Emergency medicine; SARS-CoV-2; Skin.

Conflict of interest statement

Declaration of competing interest None.

Copyright © 2020 Elsevier Inc. All rights reserved.

Figures

Fig. 1
Fig. 1
Maculopapular rash.
Fig. 2
Fig. 2
Urticaria.
Fig. 3
Fig. 3
Vesicular rash.
Fig. 4
Fig. 4
Petechial rash.
Fig. 5
Fig. 5
Chilblains of the foot.
Fig. 6
Fig. 6
Livedo reticularis of the lower extremity.
Fig. 7
Fig. 7
Necrotic toe.

References

    1. World Health Organization Situation report 110. Available at.
    1. Guan W.J., Ni Z.Y., Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
    1. Long B., Brady W.J., Koyfman A., Gottlieb M. Cardiovascular complications in COVID-19 [published online ahead of print, 2020 Apr 18] Am J Emerg Med. 2020 doi: 10.1016/j.ajem.2020.04.048.
    1. Bridwell R., Long B., Gottlieb M. Neurologic complications of COVID-19 [published online ahead of print, 2020 May 16] Am J Emerg Med. 2020 doi: 10.1016/j.ajem.2020.05.024.
    1. Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–637. Jun.
    1. Zhang H., Penninger J.M., Li Y., Zhong N., Slutsky A.S. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586–590. Apr.
    1. Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
    1. Zhou F., Yu T., Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. Mar 28.
    1. Wang D., Hu B., Hu C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020 doi: 10.1001/jama.2020.1585. Feb 7. [Epub ahead of print]
    1. Li M.Y., Li L., Zhang Y., Wang X.S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. Apr 28 2020;9(1):45. doi: 10.1186/s40249-020-00662-x.
    1. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020 doi: 10.1111/jdv.16387. [published online ahead of print, 2020 Mar 26]
    1. Henry D., Ackerman M., Sancelme E., Finon A., Esteve E. Urticarial eruption in COVID-19 infection. J Eur Acad Dermatol Venereol. 2020 doi: 10.1111/jdv.16472. [published online ahead of print, 2020 Apr 15]
    1. Genovese G., Colonna C., Marzano A.V. Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: a diagnostic clue? Pediatr Dermatol. 2020 doi: 10.1111/pde.14201. [published online ahead of print, 2020 Apr 21]
    1. Hedou M., Carsuzaa F., Chary E., Hainaut E., Cazenave-Roblot F., Masson Regnault M. Comment on “Cutaneous manifestations in COVID-19: a first perspective” by Recalcati S. J Eur Acad Dermatol Venereol. 2020 doi: 10.1111/jdv.16519. [published online ahead of print, 2020 Apr 21]
    1. Magro C., Mulvey J.J., Berlin D. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020 doi: 10.1016/j.trsl.2020.04.007. [S1931-5244(20)30070-0, published online ahead of print, 2020 Apr 15]
    1. Gianotti R., Veraldi S., Recalcati S. Cutaneous clinico-pathological findings in three COVID-19-positive patients observed in the metropolitan area of Milan, Italy. Acta Derm Venereol. 2020 doi: 10.2340/00015555-3490. [published online ahead of print, 2020 Apr 21]
    1. Sanchez A., Sohier P., Benghanem S. Digitate papulosquamous eruption associated with severe acute respiratory syndrome coronavirus 2 infection. JAMA Dermatol. 2020 doi: 10.1001/jamadermatol.2020.1704. [published online ahead of print, 2020 Apr 30]
    1. Marzano A.V., Genovese G., Fabbrocini G. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol. 2020 doi: 10.1016/j.jaad.2020.04.044. [published online ahead of print, 2020 Apr 16]
    1. Bouaziz J.D., Duong T., Jachiet M. Vascular skin symptoms in COVID-19: a french observational study. J Eur Acad Dermatol Venereol. 2020 doi: 10.1111/jdv.16544. [published online ahead of print, 2020 Apr 27]
    1. Amatore F., Macagno N., Mailhe M. SARS-CoV-2 infection presenting as a febrile rash. J Eur Acad Dermatol Venereol. 2020 doi: 10.1111/jdv.16528. [published online ahead of print, 2020 Apr 24]
    1. Gisondi P., Piaserico S., Conti A., Naldi L. Dermatologists and SARS-CoV-2: the impact of the pandemic on daily practice. J Eur Acad Dermatol Venereol. 2020 doi: 10.1111/jdv.16515. [published online ahead of print, 2020 Apr 22]
    1. Galván Casas C., Català A., Carretero Hernández G. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020 doi: 10.1111/bjd.19163. [published online ahead of print, 2020 Apr 29]
    1. Hunt M., Koziatek C. A case of COVID-19 pneumonia in a young male with full body rash as a presenting symptom. Clin Pract Cases Emerg Med. 2020 doi: 10.5811/cpcem.2020.3.47349. [published online ahead of print, 2020 Mar 28]
    1. Najarian D.J. Morbilliform Exanthem associated with COVID-19. JAAD Case Rep. 2020 doi: 10.1016/j.jdcr.2020.04.015. [published online ahead of print, 2020 Apr 20]
    1. Ahouach B., Harant S., Ullmer A. Cutaneous lesions in a patient with COVID-19: are they related? Br J Dermatol. 2020 doi: 10.1111/bjd.19168. [published online ahead of print, 2020 Apr 30]
    1. Mahé A., Birckel E., Krieger S., Merklen C., Bottlaender L. A distinctive skin rash associated with Coronavirus Disease 2019? J Eur Acad Dermatol Venereol. 2020 doi: 10.1111/jdv.16471. [published online ahead of print, 2020 Apr 15]
    1. Morey-Olivé M., Espiau M., Mercadal-Hally M., Lera-Carballo E., García-Patos V. Cutaneous manifestations in the current pandemic of coronavirus infection disease (COVID 2019) An Pediatr (Engl Ed) 2020 doi: 10.1016/j.anpede.2020.04.002. [published online ahead of print, 2020 Apr 27]
    1. Rivera-Oyola R., Koschitzky M., Printy R. Dermatologic findings in two patients with COVID-19. JAAD Case Rep. 2020 doi: 10.1016/j.jdcr.2020.04.027. [published online ahead of print, 2020 Apr 28]
    1. Estébanez A., Pérez-Santiago L., Silva E., Guillen-Climent S., García-Vázquez A., Ramón M.D. Cutaneous manifestations in COVID-19: a new contribution. J Eur Acad Dermatol Venereol. 2020 doi: 10.1111/jdv.16474. [published online ahead of print, 2020 Apr 15]
    1. Lu S., Lin J., Zhang Z. Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: a case report of familial cluster with three asymptomatic COVID-19 patients. J Med Virol. 2020 doi: 10.1002/jmv.25776. [published online ahead of print, 2020 Mar 19]
    1. Fernandez-Nieto D., Ortega-Quijano D., Segurado-Miravalles G., Pindado-Ortega C., Prieto-Barrios M., Jimenez-Cauhe J. Comment on: cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies. J Eur Acad Dermatol Venereol. 2020 doi: 10.1111/jdv.16470. [published online ahead of print, 2020 Apr 15]
    1. Quintana-Castanedo L., Feito-Rodríguez M., Valero-López I., Chiloeches-Fernández C., Sendagorta-Cudós E., Herranz-Pinto P. Urticarial exanthem as early diagnostic clue for COVID-19 infection. JAAD Case Rep. 2020 doi: 10.1016/j.jdcr.2020.04.026. [published online ahead of print, 2020 Apr 29]
    1. van Damme C., Berlingin E., Saussez S., Accaputo O. Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection. J Eur Acad Dermatol Venereol. 2020 doi: 10.1111/jdv.16523. [published online ahead of print, 2020 Apr 24]
    1. Tammaro A., Adebanjo G.A.R., Parisella F.R., Pezzuto A., Rello J. Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome. J Eur Acad Dermatol Venereol. 2020 doi: 10.1111/jdv.16530. [published online ahead of print, 2020 Apr 24]
    1. Joob B., Wiwanitkit V. COVID-19 can present with a rash and be mistaken for dengue. J Am Acad Dermatol. 2020;82(5):e177. doi: 10.1016/j.jaad.2020.03.036.
    1. Jimenez-Cauhe J., Ortega-Quijano D., Prieto-Barrios M., Moreno-Arrones O.M., Fernandez-Nieto D. Reply to “COVID-19 can present with a rash and be mistaken for Dengue”: petechial rash in a patient with COVID-19 infection. J Am Acad Dermatol. 2020 doi: 10.1016/j.jaad.2020.04.016. [published online ahead of print, 2020 Apr 10]
    1. Recalcati S., Barbagallo T., Frasin L.A. Acral cutaneous lesions in the time of COVID-19. J Eur Acad Dermatol Venereol. 2020 doi: 10.1111/jdv.16533. [published online ahead of print, 2020 Apr 24]
    1. Landa N., Mendieta-Eckert M., Fonda-Pascual P., Aguirre T. Chilblain-like lesions on feet and hands during the COVID-19 Pandemic. Int J Dermatol. 2020 doi: 10.1111/ijd.14937. [published online ahead of print, 2020 Apr 24]
    1. Uthman I.W., Khamashta M.A. Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome. J Rheumatol. 2006;33(12):2379–2382.
    1. Manalo I.F., Smith M.K., Cheeley J., Jacobs R. A dermatologic manifestation of COVID-19: transient livedo reticularis. J Am Acad Dermatol. 2020 doi: 10.1016/j.jaad.2020.04.018. [published online ahead of print, 2020 Apr 10]
    1. Zhang Y., Cao W., Xiao M. Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia. Zhonghua Xue Ye Xue Za Zhi. 2020;41(0) doi: 10.3760/cma.j.issn.0253-2727.2020.0006.
    1. Alramthan A., Aldaraji W. A case of COVID-19 presenting in clinical picture resembling chilblains disease. First report from the Middle East. Clin Exp Dermatol. 2020 doi: 10.1111/ced.14243. [published online ahead of print, 2020 Apr 17]
    1. Mazzotta F., Troccoli T. Acute Acro-ischemia in the child at the time of COVID-19. Dermatologia Pediatrica. 2020 Available at.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren